Ok, C. Y., Xu-Monette, Z. Y., Visco, C., Tzankov, A., Montes-Moreno, S., Dybkær, K., … Young, K. H. (2014). Prevalence and Clinical Implications of Epstein-Barr Virus Infection in de novo Diffuse Large B-Cell Lymphoma in Western Countries: A report from The International DLBCL Rituximab-CHOP Consortium Program. In Clinical Lymphoma Myeloma and Leukemia (Vol. 14, pp. S144–S145). Elsevier BV. https://doi.org/10.1016/j.clml.2014.06.082

Ok, Chi Young, Zijun Y. Xu-Monette, Carlo Visco, Alexandar Tzankov, Santiago Montes-Moreno, Karen Dybkær, April Chiu, et al. “Prevalence and Clinical Implications of Epstein-Barr Virus Infection in de novo Diffuse Large B-Cell Lymphoma in Western Countries: A report from The International DLBCL Rituximab-CHOP Consortium Program.” In Clinical Lymphoma Myeloma and Leukemia, 14:S144–45. Elsevier BV, 2014. https://doi.org/10.1016/j.clml.2014.06.082.

Ok CY, Xu-Monette ZY, Visco C, Tzankov A, Montes-Moreno S, Dybkær K, et al. Prevalence and Clinical Implications of Epstein-Barr Virus Infection in de novo Diffuse Large B-Cell Lymphoma in Western Countries: A report from The International DLBCL Rituximab-CHOP Consortium Program. In: Clinical Lymphoma Myeloma and Leukemia. Elsevier BV; 2014. p. S144–5.

Ok, Chi Young, et al. “Prevalence and Clinical Implications of Epstein-Barr Virus Infection in de novo Diffuse Large B-Cell Lymphoma in Western Countries: A report from The International DLBCL Rituximab-CHOP Consortium Program.” Clinical Lymphoma Myeloma and Leukemia, vol. 14, Elsevier BV, 2014, pp. S144–45. Crossref, doi:10.1016/j.clml.2014.06.082.

Ok CY, Xu-Monette ZY, Visco C, Tzankov A, Montes-Moreno S, Dybkær K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WWL, van Krieken JH, Huh J, Ai W, Ponzoni M, Ferreri AJM, Farnen JP, Møller MB, Bueso-Ramos CE, Winter JN, Piris MA, Medeiros LJ, Young KH. Prevalence and Clinical Implications of Epstein-Barr Virus Infection in de novo Diffuse Large B-Cell Lymphoma in Western Countries: A report from The International DLBCL Rituximab-CHOP Consortium Program. Clinical Lymphoma Myeloma and Leukemia. Elsevier BV; 2014. p. S144–S145.